Immatics NV (IMTX)
7.59
-0.85
(-10.07%)
USD |
NASDAQ |
Oct 02, 16:00
7.60
+0.01
(+0.13%)
After-Hours: 20:00
Immatics Enterprise Value : 604.46M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 604.46M |
| October 01, 2026 | 720.65M |
| September 30, 2026 | 767.12M |
| September 29, 2026 | 737.05M |
| September 28, 2026 | 728.85M |
| September 25, 2026 | 711.08M |
| September 24, 2026 | 705.61M |
| September 23, 2026 | 742.52M |
| September 22, 2026 | 779.42M |
| September 21, 2026 | 758.92M |
| September 18, 2026 | 745.25M |
| September 17, 2026 | 772.59M |
| September 16, 2026 | 747.98M |
| September 15, 2026 | 742.52M |
| September 14, 2026 | 745.25M |
| September 11, 2026 | 768.49M |
| September 10, 2026 | 763.02M |
| September 09, 2026 | 812.23M |
| September 08, 2026 | 857.34M |
| September 04, 2026 | 873.74M |
| September 03, 2026 | 860.07M |
| September 02, 2026 | 865.54M |
| September 01, 2026 | 855.97M |
| August 31, 2026 | 869.64M |
| August 28, 2026 | 858.70M |
| Date | Value |
|---|---|
| August 27, 2026 | 846.40M |
| August 26, 2026 | 855.97M |
| August 25, 2026 | 830.00M |
| August 24, 2026 | 754.82M |
| August 21, 2026 | 787.62M |
| August 20, 2026 | 735.68M |
| August 19, 2026 | 831.36M |
| August 18, 2026 | 809.49M |
| August 17, 2026 | 831.36M |
| August 14, 2026 | 857.34M |
| August 13, 2026 | 877.84M |
| August 12, 2026 | 894.24M |
| August 11, 2026 | 899.71M |
| August 10, 2026 | 895.61M |
| August 07, 2026 | 886.04M |
| August 06, 2026 | 854.60M |
| August 05, 2026 | 902.44M |
| August 04, 2026 | 849.13M |
| August 03, 2026 | 799.93M |
| July 31, 2026 | 750.72M |
| July 30, 2026 | 824.53M |
| July 29, 2026 | 795.82M |
| July 28, 2026 | 760.97M |
| July 27, 2026 | 746.62M |
| July 24, 2026 | 808.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MediGene AG | -- |
| InflaRx NV | 73.20M |
| BioNTech SE | 7.809B |
| Twist Bioscience Corp. | 11.75B |
| Prime Medicine, Inc. | 556.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -72.66M |
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 83.29M |
| EPS Diluted (Quarterly) | -0.5316 |
| Profit Margin (Quarterly) | -683.4% |
| Earnings Yield | -24.37% |
| Normalized Earnings Yield | -24.38 |